Amgen Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Portfolio Pulse from Avi Kapoor
Amgen Inc. (NASDAQ:AMGN) is set to release its Q2 earnings on Aug. 6, with analysts expecting slight increases in EPS and significant revenue growth. The company declared a $2.25 per share dividend for Q3 2024. Recent analyst ratings show mixed sentiments, with price targets ranging from $303 to $355.
August 06, 2024 | 3:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Amgen is expected to report Q2 earnings with a slight increase in EPS and significant revenue growth. The company declared a $2.25 per share dividend for Q3 2024. Recent analyst ratings show mixed sentiments, with price targets ranging from $303 to $355.
The expected increase in EPS and significant revenue growth are positive indicators for Amgen's stock. The declared dividend further adds to investor confidence. However, mixed analyst ratings and recent price target adjustments suggest some uncertainty.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100